NASDAQ:OPHT - Ophthotech News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.50 -0.05 (-3.23 %)
(As of 03/21/2019 04:00 PM ET)
Previous Close$1.55
Today's Range$1.49 - $1.55
52-Week Range$1.02 - $4.50
Volume144,324 shs
Average Volume294,776 shs
Market Capitalization$62.13 million
P/E Ratio-0.90
Dividend YieldN/A
Beta1.49

Headlines

Ophthotech (NASDAQ OPHT) News Headlines

Source:
DateHeadline
Ophthotech CorpOphthotech Corp
www.bloomberg.com - March 19 at 8:30 AM
Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor DayOphthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day
finance.yahoo.com - March 14 at 8:21 AM
If You Had Bought Ophthotech (NASDAQ:OPHT) Stock Three Years Ago, You’d Be Sitting On A 96% Loss, TodayIf You Had Bought Ophthotech (NASDAQ:OPHT) Stock Three Years Ago, You’d Be Sitting On A 96% Loss, Today
finance.yahoo.com - March 12 at 10:53 PM
 Brokerages Expect Ophthotech Corp (OPHT) Will Post Earnings of -$0.36 Per Share Brokerages Expect Ophthotech Corp (OPHT) Will Post Earnings of -$0.36 Per Share
www.americanbankingnews.com - March 10 at 10:25 AM
Ophthotech to Present at the Cowen and Company 39th Annual Health Care ConferenceOphthotech to Present at the Cowen and Company 39th Annual Health Care Conference
finance.yahoo.com - March 6 at 8:21 AM
Ophthotechs (OPHT) Q4 Loss Wider, Gene Therapy in FocusOphthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus
www.zacks.com - February 27 at 7:25 PM
Edited Transcript of OPHT earnings conference call or presentation 26-Feb-19 1:00pm GMTEdited Transcript of OPHT earnings conference call or presentation 26-Feb-19 1:00pm GMT
finance.yahoo.com - February 27 at 8:14 AM
BRIEF-Ophthotech Reports Q4 And FY2018 Financial ResultsBRIEF-Ophthotech Reports Q4 And FY2018 Financial Results
www.msn.com - February 26 at 6:47 PM
Ophthotech Corporation (OPHT) CEO Glenn Sblendorio on Q4 2018 Results - Earnings Call TranscriptOphthotech Corporation (OPHT) CEO Glenn Sblendorio on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - February 26 at 6:47 PM
Ophthotech Corp (OPHT) Reports Q4 EPS of $2.62 - StreetInsider.comOphthotech Corp (OPHT) Reports Q4 EPS of $2.62 - StreetInsider.com
www.streetinsider.com - February 26 at 8:15 AM
Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating ResultsOphthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
finance.yahoo.com - February 26 at 8:15 AM
U.S. STOCKS ON THE MOVE- GE, Spark Therapeutics, IMAX - NasdaqU.S. STOCKS ON THE MOVE- GE, Spark Therapeutics, IMAX - Nasdaq
www.nasdaq.com - February 25 at 7:08 PM
U.S. STOCKS ON THE MOVE-GE, Spark Therapeutics, chip stocks - NasdaqU.S. STOCKS ON THE MOVE-GE, Spark Therapeutics, chip stocks - Nasdaq
www.nasdaq.com - February 25 at 7:08 PM
U.S. STOCKS ON THE MOVE-GE, Anaplan, Nio, Titan Pharmaceuticals, Spark Therapeutics - NasdaqU.S. STOCKS ON THE MOVE-GE, Anaplan, Nio, Titan Pharmaceuticals, Spark Therapeutics - Nasdaq
www.nasdaq.com - February 25 at 7:08 PM
Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019
finance.yahoo.com - February 19 at 8:11 AM
Recent Analysis Shows Amerco, McKesson, Ophthotech, IQVIA, Highwoods Properties, and ABM Industries Market Influences — Renewed Outlook, Key Drivers of GrowthRecent Analysis Shows Amerco, McKesson, Ophthotech, IQVIA, Highwoods Properties, and ABM Industries Market Influences — Renewed Outlook, Key Drivers of Growth
finance.yahoo.com - February 8 at 8:13 AM
Ophthotech (OPHT) Presents At 37th Annual J.P. Morgan Healthcare Conference - SlideshowOphthotech (OPHT) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 11 at 6:45 PM
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare ConferenceOphthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 8:16 AM
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of DirectorsOphthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors
finance.yahoo.com - January 2 at 8:16 AM
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of DirectorsOphthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors
finance.yahoo.com - December 12 at 4:22 PM
Ophthotech (OPHT) Down 21.7% Since Last Earnings Report: Can It Rebound?Ophthotech (OPHT) Down 21.7% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - November 30 at 5:58 PM
Ophthotech Corp (OPHT) Reports Results from Phase 2a Safety Trial of Zimura (avacincaptad pegol) in Combination ...Ophthotech Corp (OPHT) Reports Results from Phase 2a Safety Trial of Zimura (avacincaptad pegol) in Combination ...
www.streetinsider.com - November 14 at 5:24 PM
BRIEF-Ophthotech Announces Results From Phase 2A Safety Trial Of Zimura In Combination With Lucentis In Wet Age-Related Macular DegenerationBRIEF-Ophthotech Announces Results From Phase 2A Safety Trial Of Zimura In Combination With Lucentis In Wet Age-Related Macular Degeneration
www.msn.com - November 12 at 8:17 AM
Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular DegenerationOphthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration
finance.yahoo.com - November 12 at 8:17 AM
Form 10-Q Ophthotech Corp. For: Sep 30Form 10-Q Ophthotech Corp. For: Sep 30
www.streetinsider.com - November 4 at 8:16 AM
Form 8-K Ophthotech Corp. For: Oct 30Form 8-K Ophthotech Corp. For: Oct 30
www.streetinsider.com - November 2 at 8:09 AM
Ophthotech (OPHT) Q3 Earnings Beat, Gene Therapy in FocusOphthotech (OPHT) Q3 Earnings Beat, Gene Therapy in Focus
finance.yahoo.com - November 1 at 6:11 PM
Edited Transcript of OPHT earnings conference call or presentation 31-Oct-18 12:00pm GMTEdited Transcript of OPHT earnings conference call or presentation 31-Oct-18 12:00pm GMT
finance.yahoo.com - November 1 at 8:07 AM
Ophthotech Corporation 2018 Q3 - Results - Earnings Call SlidesOphthotech Corporation 2018 Q3 - Results - Earnings Call Slides
seekingalpha.com - October 31 at 5:35 PM
Ophthotech Corporation (OPHT) CEO Glenn Sblendorio on Q3 2018 Results - Earnings Call TranscriptOphthotech Corporation (OPHT) CEO Glenn Sblendorio on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - October 31 at 5:35 PM
Ophthotech acquires Inception 4 in all-stock dealOphthotech acquires Inception 4 in all-stock deal
seekingalpha.com - October 31 at 8:13 AM
Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4
finance.yahoo.com - October 31 at 8:13 AM
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease)Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease)
finance.yahoo.com - October 31 at 8:13 AM
Ophthotech Reports Third Quarter 2018 Financial and Operating ResultsOphthotech Reports Third Quarter 2018 Financial and Operating Results
finance.yahoo.com - October 31 at 8:13 AM
Ophthotech: 3Q Earnings SnapshotOphthotech: 3Q Earnings Snapshot
finance.yahoo.com - October 31 at 8:13 AM
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday ...Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday ...
www.businesswire.com - October 23 at 8:11 AM
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018
finance.yahoo.com - October 23 at 8:11 AM
Form 8-K Ophthotech Corp. For: Oct 04Form 8-K Ophthotech Corp. For: Oct 04
www.streetinsider.com - October 5 at 8:16 AM
Ophthotech completes patient recruitment for its Phase 2b clinical trial of ZimuraOphthotech completes patient recruitment for its Phase 2b clinical trial of Zimura
seekingalpha.com - October 4 at 4:56 PM
Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular DegenerationOphthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
finance.yahoo.com - October 4 at 8:11 AM
Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines ConferenceOphthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference
finance.yahoo.com - October 3 at 8:17 AM
Is Ophthotech Corporation (NASDAQ:OPHT) Attractive At Its Current PE Ratio?Is Ophthotech Corporation (NASDAQ:OPHT) Attractive At Its Current PE Ratio?
finance.yahoo.com - September 12 at 4:54 PM
Why Is Ophthotech (OPHT) Up 5.8% Since Last Earnings Report?Why Is Ophthotech (OPHT) Up 5.8% Since Last Earnings Report?
finance.yahoo.com - August 31 at 5:19 PM
Ophthotech Corp (OPHT) Says Data for Adeno-Associated Virus Gene Therapy in RHO-adRP Published in PNASOphthotech Corp (OPHT) Says Data for Adeno-Associated Virus Gene Therapy in RHO-adRP Published in PNAS
www.streetinsider.com - August 22 at 5:04 PM
Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of SciencesScientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences
finance.yahoo.com - August 22 at 8:17 AM
Report: Developing Opportunities within Energy Recovery, Lamb Weston, Neurocrine Biosciences, Pioneer Natural Resources, Meritor, and Ophthotech — Future Expectations, Projections Moving into 2018Report: Developing Opportunities within Energy Recovery, Lamb Weston, Neurocrine Biosciences, Pioneer Natural Resources, Meritor, and Ophthotech — Future Expectations, Projections Moving into 2018
finance.yahoo.com - August 13 at 8:09 AM
Form 10-Q Ophthotech Corp. For: Jun 30Form 10-Q Ophthotech Corp. For: Jun 30
www.streetinsider.com - August 3 at 4:40 PM
Edited Transcript of OPHT earnings conference call or presentation 1-Aug-18 12:00pm GMTEdited Transcript of OPHT earnings conference call or presentation 1-Aug-18 12:00pm GMT
finance.yahoo.com - August 2 at 8:12 AM
Ophthotech Corp (OPHT) CEO Glenn Sblendorio on Q2 2018 Results - Earnings Call TranscriptOphthotech Corp (OPHT) CEO Glenn Sblendorio on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 1 at 5:59 PM
Ophthotech Corp (OPHT) Tops Q2 EPS by 2cOphthotech Corp (OPHT) Tops Q2 EPS by 2c
www.streetinsider.com - August 1 at 5:59 PM
This page was last updated on 3/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel